Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232492
Status:
COMPLETED
Last Update Posted:
2011-07-06
First Post:
2005-09-30
Brief Title:
Ketamine on Acute Pain in Females and Males
Sponsor:
Ullevaal University Hospital
Organization:
Oslo University Hospital
Study Overview
Official Title:
Effect of Racemic Ketamine on Pain in Females and Males After Surgical Removal of Third Molars
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether equal subanesthetic doses of racemic ketamine is equally effective on females and males after surgical removal of third molars
Detailed Description:
Ketamine is assumed to be a NMDA receptor antagonist which provides analgesia from acute postoperative painand other types of pain subanesthetic doses Gender differences in ketamine analgesia are not known This placebo-controlledrandomised parallel group study investigates the analgesic dose-response effect of ketamine in subanesthetic doses in female and male patients following surgical removal of third molars
Comparisons Placebo and ketamine in females and males
Comparisons Placebo and ketamine in females and males
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None